{
  "id": 3024,
  "text": "921.Kasamatsu, T., et al.Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.Br J Cancer 100, 1400-1405 (2009).922.Hu, T., et al.Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 921.Kasamatsu, T., et al.Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.Br J Cancer 100, 1400-1405 (2009).922.Hu, T., et al.Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "评估宫颈癌患者在进行根治性手术时是否需要保留卵巢，需综合考虑以下因素：\n\n1. **患者的年龄**：年轻患者，特别是尚未达到自然绝经年龄者，通常倾向于保留卵巢以维持内分泌功能，减少早发性更年期及相关并发症的风险。\n\n2. **肿瘤分期**：对于FIGO I期肿瘤患者，如果肿瘤局限于宫颈、未侵及卵巢，且无高危因素（如腺癌或者较高的淋巴结转移风险），可能考虑卵巢保留。\n\n3. **肿瘤类型**：腺癌类型的宫颈癌患者其卵巢转移风险更高，因此更需谨慎评估保留卵巢的可能性。\n\n4. **影像学和术中检查**：术前通过PET-CT或MRI详细评估有无卵巢转移可能性，术中也需注意卵巢外观是否正常，确保无明显转移或病变。\n\n5. **辅助治疗计划**：若患者计划接受术后放疗，则通常不建议保留卵巢，因为放疗可能导致卵巢功能的不可逆损伤。\n\n综上，应结合患者的年龄、肿瘤分期、组织学类型以及术前检查结果进行全面评估，制定个性化治疗方案，以便在控制肿瘤的同时尽可能改善患者的生活质量。",
  "query": "宫颈癌患者在进行根治性手术时，如何评估是否需要保留卵巢？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 宫颈癌患者在进行根治性手术时，如何评估是否需要保留卵巢？\n\n<reference text>: 921.Kasamatsu, T., et al.Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix.Br J Cancer 100, 1400-1405 (2009).922.Hu, T., et al.Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "评估宫颈癌患者在进行根治性手术时是否需要保留卵巢，需综合考虑以下因素：\n\n1. **患者的年龄**：年轻患者，特别是尚未达到自然绝经年龄者，通常倾向于保留卵巢以维持内分泌功能，减少早发性更年期及相关并发症的风险。\n\n2. **肿瘤分期**：对于FIGO I期肿瘤患者，如果肿瘤局限于宫颈、未侵及卵巢，且无高危因素（如腺癌或者较高的淋巴结转移风险），可能考虑卵巢保留。\n\n3. **肿瘤类型**：腺癌类型的宫颈癌患者其卵巢转移风险更高，因此更需谨慎评估保留卵巢的可能性。\n\n4. **影像学和术中检查**：术前通过PET-CT或MRI详细评估有无卵巢转移可能性，术中也需注意卵巢外观是否正常，确保无明显转移或病变。\n\n5. **辅助治疗计划**：若患者计划接受术后放疗，则通常不建议保留卵巢，因为放疗可能导致卵巢功能的不可逆损伤。\n\n综上，应结合患者的年龄、肿瘤分期、组织学类型以及术前检查结果进行全面评估，制定个性化治疗方案，以便在控制肿瘤的同时尽可能改善患者的生活质量。"
}